Recently, xCT inhibition was suggested as a potential therapeutic strategy for cancer due to the depletion of GSH and induction of ferroptosis, which is an iron- and ROS-dependent form of regulated cell death [20,21,22,23]. Here, SLC7A11 is linked to cancer.